Evidence map›Paper›PMID 38727292›Full record

ArticleCells2024

Selective Targeting of α

Biki Gupta, Ravi Prakash Rai, Pabitra B Pal, Daniel Rossmiller, Sudrishti Chaudhary, Anna Chiaro, Shannon Seaman, Aatur D Singhi, Silvia Liu, Satdarshan P Monga and 2 more

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Integrating mechanical cues inFrontiers in immunology · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Biki GuptaDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Ravi Prakash RaiDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.ORCID 0000-0003-2550-3811
Pabitra B PalDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Daniel RossmillerDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Sudrishti ChaudharyDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Anna ChiaroDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Shannon SeamanDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Aatur D SinghiPittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Silvia LiuDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.ORCID 0000-0002-1840-9520
Satdarshan P MongaDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.ORCID 0000-0002-8437-3378
Smita S IyerDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Reben RaemanDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

Funding

Pittsburgh Liver Research CenterP30DK120531 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CLAUDETTE Marie ST CROIX · 2019 to 2026
$10.9M
Role of Wnt/Beta-Catenin Signaling in Liver DevelopmentR01DK062277 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Satdarshan Singh Monga · 2004 to 2026
$9.0M
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver diseaseR01DK124351 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAEMAN, REBEN · 2021 to 2025
$2.1M
Targeting beta-catenin in liver pathology: Novel Interactions, Novel ParadigmsR01DK100287 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MONGA, SATDARSHAN SINGH · 2013 to 2016
$1.3M
Targeting CD4 T follicular helper cells for enhancing HIV vaccine induced humoral immunityR56AI150409 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IYER, SWAMINATHAN SMITA · 2021 to 2021
$774k
Role of CD4 T cells in the pathogenesis of non-alcoholic steatohepatitisK01DK110264 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAEMAN, REBEN · 2017 to 2021
$702k
NIAID NIH HHS R56 AI150409NIDDK NIH HHS K01 DK110264NIDDK NIH HHS K01DK110264NIDDK NIH HHS P30 DK120531NIDDK NIH HHS P30DK120531NIDDK NIH HHS R01 DK062277NIDDK NIH HHS R01 DK100287NIDDK NIH HHS R01 DK124351NIDDK NIH HHS R01DK124351NIH HHS R01DK100287NIH HHS R56AI150409NIH HHS RF1AG06001
6 · The paper itself

Abstract

Integrin α

Indexed as

Cell Adhesion MoleculesDisease ProgressionIntegrinsLiverLiver CirrhosisMucoproteinsAnimalsAntibodies, MonoclonalCarbon TetrachlorideCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDisease Models, AnimalFemaleHumansImmunoglobulinsInflammationAntibodies, MonoclonalCarbon TetrachlorideCell Adhesion MoleculesImmunoglobulinsintegrin alpha4beta7IntegrinsMADCAM1 protein, humanMadcam1 protein, mouseMucoproteinschronic liver diseasecirrhosisfibrosisinflammationT cells

Identifiers

PMID38727292
PMCPMC11083209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.